Patent details

Basic Information

Publication number:

EP1330261

PCT Application Number:

PCT/US/2001/032559

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019831692

PCT Publication Number:

WO/2002/034285

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF HIBERNATING MYOCARDIUM AND DIABETIC CARDIOMYOPATHY WITH A GLP-1 PEPTIDE

French Title of Invention:

TRAITEMENT DU MYOCARDE HIBERNANT ET DE LA CARDIOMIOPATHIE DIAB TIQUE PAR UN PEPTIDE GLP-1

German Title of Invention:

BEHANDLUNG VON HYPOAKTIVEM MYOKARD UND DIABETISCHER HERZMYOPATHIE MIT EINEM GLP-1 PEPTID

SPC Number:

Dates

Filing date:

22/10/2001

Grant date:

09/06/2010

EP Publication Date:

09/06/2010

PCT Publication Date:

02/05/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/07/2003

EP B1 Publication Date:

09/06/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/10/2010

Expiration date:

22/10/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/10/2001

 

 

Name:

AMYLIN PHARMACEUTICALS INC.

Address:

9373 Towne Centre Drive, San Diego, California 92121, United States (US)

Inventor

1

Name:

Thomas R. COOLIDGE

Address:

United States (US)

2

Name:

EHLERS Mario

Address:

United States (US)

Priority

1

Priority Number:

241834 P

Priority Date:

20/10/2000

Priority Country:

United States (US)

2

Priority Number:

242139 P

Priority Date:

23/10/2000

Priority Country:

United States (US)

3

Priority Number:

245234 P

Priority Date:

03/11/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/26;

Filing date	Document type	Number of pages